Exiqon and Takara Bio Partner in the Distribution of Products in Asia
News Oct 24, 2012
In addition to this new distribution of products, Takara Bio plans to launch contract research services utilizing Exiqon 's products in Japan on December 10, 2012.
MicroRNAs are single-stranded RNAs that are approximately 18 to 26 nucleotides in length, and play key roles in the regulation of gene expression which is essential for living organisms. miRNA research has received a lot of attention in recent years, and has been strongly promoted in the field of cancer research, stem cell research, developmental biology and neuroscience.
Exiqon has its own proprietary LNA™ (Locked Nucleic Acid) technology which makes it unique and puts it well ahead of its competitors. This technology platform offers global miRNA detection or expression profiling with unmatched specificity and sensitivity.
With the addition of Exiqon's competitive products, Takara Bio will continue to offer a comprehensive range of new and innovative products and services which will enhance the convenience of customers.
Streaming Protocol Makes Gene Data Sharing Future-ProofNews
The Large Scale Genomics Work Stream of the Global Alliance for Genomics and Health (GA4GH) has announced eight new implementations of its htsget protocol, a standard released in October 2017 for accessing large-scale genomic sequencing data online that does not depend on file transfers. The protocol and interoperability testing are reported in a paper released online this week in the journal Bioinformatics.
Antiviral Gene Vanquishes ZikaNews
It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene’s success: The enzyme it codes for generates a compound that stops viruses from replicating. The newly discovered compound, described in today’s online edition of Nature, offers a novel approach for attacking many disease-causing viruses.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.